Author

Jieqiong Liu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Aug 2026

Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab plus apatinib as a chemotherapy-free strategy for early-stage triple-negative breast cancer: a phase II study

Camrelizumab plus apatinib demonstrated manageable toxicity and preliminary antitumor activity, supporting further investigation of this chemotherapy-free strategy in early-stage TNBC patients with enriched TILs.

Z. Tian, Heng-Yu Li, Yujun Deng et al. · Breast Cancer Research and T... · 0 citations

Review

The Predictive Accuracy of PREDICT:A Personalized Decision-Making Tool for Southeast Asian Women With Breast Cancer

This population-based study suggests that several initial cancers are associated with elevated risk of CCA, and the increased risk may be due to shared genetic or environmental etiological factors between these malignancies.

M. Kai, Wen Jiang, Jieqiong Liu et al. · 0 citations